|
Thrombin
Citations 51-60 of 60 total displayed.
|
Past content
(since Nov 2000):
|
- Correspondence
Oral Anticoagulation Therapy During and After Coronary Angioplasty
- Uichi Ikeda, Kazuyuki Shimada, Jurriën M. ten Berg, Johannes C. Kelder, H.W. Thijs Plokker, Barbara A. Hutten, and Freek W.A. Verheugt
Circulation 2001;104:e150
[Full text]
- Basic Science Reports
Sex Steroids Used in Hormonal Treatment Increase Vascular Procoagulant Activity by Inducing Thrombin Receptor (PAR-1) Expression: Role of the Glucocorticoid Receptor
- Olaf Herkert, Herbert Kuhl, Jurgen Sandow, Rudi Busse, and Valérie B. Schini-Kerth
Circulation 2001;104:2826-2831, doi:10.1161/hc4801.099737
[Abstract]
[Full text]
- Clinical Investigations and Reports
PlA2 Polymorphism of ß3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury
- Anetta Undas, Kathleen Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2001;104:2666-2672, doi:10.1161/hc4701.099787
[Abstract]
[Full text]
- Clinical Investigations and Reports
Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin: Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II)
- Allan M. Ross, Peter Molhoek, Conor Lundergan, Merrill Knudtson, Yasmine Draoui, Lorna Regalado, Veronique Le Louer, Frederique Bigonzi, Whitney Schwartz, Egbert de Jong, and Karin Coyne
Circulation 2001;104:648-652, doi:10.1161/hc3101.093866
[Abstract]
[Full text]
- Brief Rapid Communications
Deficiency of Tissue Factor Pathway Inhibitor Promotes Atherosclerosis and Thrombosis in Mice
- Randal J. Westrick, Peter F. Bodary, ZuoJun Xu, Yue-Chun Shen, George J. Broze, and Daniel T. Eitzman
Circulation 2001;103:3044-3046, doi:10.1161/hc2501.092492
[Abstract]
[Full text]
- Clinical Investigations and Reports
Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction : A TIMI 14 Substudy
- C. Michael Gibson, James A. de Lemos, Sabina A. Murphy, Susan J. Marble, Carolyn H. McCabe, Christopher P. Cannon, Elliott M. Antman, and Eugene Braunwald
Circulation 2001;103:2550-2554
[Abstract]
[Full text]
- Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Generate Thrombin During Inhibition of Tissue Factor in Human Subjects
- Philip W. Friederich, Marcel Levi, Kenneth A. Bauer, George P. Vlasuk, William E. Rote, Daan Breederveld, Tijmen Keller, Marco Spataro, Samad Barzegar, and Harry R. Büller
Circulation 2001;103:2555-2559
[Abstract]
[Full text]
- Brief Rapid Communications
Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary -Radiation in Patients With In-Stent Restenosis : Washington Radiation for In-Stent Restenosis Trial Plus 6 Months of Clopidogrel (WRIST PLUS)
- Ron Waksman, Andrew E. Ajani, R. Larry White, Ellen Pinnow, Regina Dieble, Anh B. Bui, Maeve Taaffe, Luis Gruberg, Gary S. Mintz, Lowell F. Satler, Augusto D. Pichard, Kenneth K. Kent, and Joseph Lindsay
Circulation 2001;103:2332-2335
[Abstract]
[Full text]
- Cardiovascular Drugs
The Search for Replacements for Unfractionated Heparin
- Elliott M. Antman
Circulation 2001;103:2310-2314
[Full text]
- Correspondence
Plasma Urokinase Antigen and Plasminogen Activator Inhibitor-1 Antigen Levels Predict Angiographic Coronary Restenosis
- Uichi Ikeda, Yukihiro Hojo, and Kazuyuki Shimada
Circulation 2000;102:e167
[Full text]
|
|